Literature DB >> 11884776

Risk of significant coronary artery disease as determined by CT measurement of the distribution of abdominal adipose tissue.

Ahmet T Tirkes1, Ronald H Gottlieb, Susan L Voci, David L Waldman, Jeffrey Masetta, David L Conover.   

Abstract

PURPOSE: The purpose of this work was to determine if CT measurement of the distribution of abdominal adipose tissue is reproducible between observers and is associated with patient risk of significant coronary artery disease.
METHOD: We compared 11 male patients having abdominal CT who had a history of significant coronary artery disease and 9 male patients having abdominal CT without a history of coronary artery disease. Two observers, at the level of the umbilicus, independently measured the ratio of visceral adipose tissue (VAT) to total abdominal adipose tissue (TAT). VAT is equal to the sum total of intraperitoneal and retroperitoneal adipose tissue. TAT equals the sum total of visceral and subcutaneous adipose tissue. Measurements were made using a standard software package.
RESULTS: The mean ratio of VAT to TAT was significantly different (p < 0.05) between patients with a history of coronary artery disease (mean = 0.51, SD = 0.10, range = 0.38-0.69) and without a history of coronary artery disease (mean = 0.40, SD = 0.12, range = 0.23-0.51). Agreement in measurements between observers was excellent (mean difference = 0.01, range = 0.00-0.03, intraclass correlation = 0.99).
CONCLUSION: The measurement of the VAT/TAT ratio is highly reproducible between observers, and a high ratio is associated with patient risk of significant coronary artery disease.

Entities:  

Mesh:

Year:  2002        PMID: 11884776     DOI: 10.1097/00004728-200203000-00009

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  1 in total

1.  The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus.

Authors:  Tae Ho Kim; Seong Su Lee; Ji Han Yoo; Sung Rae Kim; Soon Jib Yoo; Ho Cheol Song; Yong-Soo Kim; Euy Jin Choi; Yong Kyun Kim
Journal:  Diabetol Metab Syndr       Date:  2012-02-03       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.